NCT07365995
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07365995
Title A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors BioNTech SE
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Rocky Mountain Cancer Centers RECRUITING Aurora Colorado 80012 United States Details
Florida Cancer Specialists- Fort Myers RECRUITING Fort Myers Florida 33901 United States Details
Florida Cancer Specialists- St. Petersburg RECRUITING St. Petersburg Florida 33701 United States Details
Florida Cancer Specialists- West Palm Beach RECRUITING West Palm Beach Florida 33401 United States Details
Illinois Cancer Specialists RECRUITING Niles Illinois 60714 United States Details
Illinois CancerCare PC RECRUITING Peoria Illinois 61615 United States Details
Maryland Oncology Hematology RECRUITING Rockville Maryland 20850 United States Details
Oncology/Hematology Care, Inc. RECRUITING Cincinnati Ohio 45242 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology South Austin RECRUITING Austin Texas 78731 United States Details
Texas Oncology Gulf Coast RECRUITING Houston Texas 77024 United States Details
Texas Oncology, P.A. - Tyler RECRUITING Tyler Texas 75702 United States Details
Texas Oncology - West Texas RECRUITING Wichita Falls Texas 76310 United States Details
Virginia Cancer Specialists PC RECRUITING Fairfax Virginia 22031 United States Details
Virginia Oncology Associates RECRUITING Norfolk Virginia 23502 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field